From: The women’s heart health programme: a pilot trial of sex-specific cardiovascular management
Control (n = 50) | Intervention (n = 50) | p-value | |
---|---|---|---|
Body-mass-index (kg/m2) | |||
Baseline | 26.1 (23.0-29.6) | 25.7 (23.3-28.3) | 0.539 |
1-Year | 25.2 (22.5-28.8) | 23.7 (22.5-26.9) | 0.318 |
Systolic Blood Pressure (mmHg) | |||
Baseline | 138 (120-150) | 140.5 (130-153) | 0.292 |
1-Year | 137 (123-154) | 140.0 (127-153) | 0.702 |
Glycated Haemoglobin, Hba1C (%) | |||
Baseline | 6.2 (5.6-6.7) | 6.3 (5.7-7.4) | 0.263 |
1-Year | 6.3 (5.6-8.2) | 6.2 (5.7-6.7) | 0.202 |
Low Density Lipoprotein (mmol/L) | |||
Baseline | 2.5 (1.9-3.0) | 2.2 (1.9-3.0) | 0.712 |
1-Year | 2.3 (1.8-2.7) | 2.4 (1.9-2.9) | 0.465 |
High Density Lipoprotein (mmol/L) | |||
Baseline | 1.3 (1.1-1.5) | 1.3 (1.1-1.6) | 0.344 |
1-Year | 1.2 (1.0-1.5) | 1.3 (1.1-1.5) | 0.369 |
MOS SF-36 Scores | |||
Baseline | |||
Physical Component Score | 51.9 (38.1-67.5) | 61.3 (44.4-78.1) | 0.077 * |
Mental Component Score | 54.6 (31.5-81.3) | 79.3 (56.0-86.3) | 0.014 * |
1-Year | |||
Physical Component Score | 71.3 (48.8-83.1) | 77.5 (57.5-86.3) | 0.160 |
Mental Component Score | 79.4 (62.1-88.0) | 81.0 (65.0-92.0) | 0.613 |
Admissions (Cardiovascular) | 8 (16%) | 8 (16%) | 0.999 |
All-Cause Mortality Status | 2 (4%) | 2 (4%) | 0.999 |
Cardiovascular Event | 5 (10%) | 4 (8%) | 0.727 |